Share on StockTwits
 

iBio (NASDAQ:IBIO) major shareholder Carl Desantis sold 74,049 shares of the stock on the open market in a transaction dated Friday, January 31st. The shares were sold at an average price of $0.56, for a total value of $41,467.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

iBio (NASDAQ:IBIO) traded down 4.03% during mid-day trading on Friday, hitting $0.5758. 288,287 shares of the company’s stock traded hands. iBio has a 52 week low of $0.28 and a 52 week high of $0.85. The stock’s 50-day moving average is $0.43 and its 200-day moving average is $0.42. The company’s market cap is $37.1 million.

iBio, Inc is a biotechnology company focused on commercializing its technology, the iBioLaunch platform, for the production of biologics, including vaccines and therapeutic proteins.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.